• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

粪菌移植用于根除幽门螺杆菌感染:临床实践与理论假设

Faecal microbiota transplantation for eradicating Helicobacter pylori infection: clinical practice and theoretical postulation.

作者信息

Ye Zhi-Ning, Eslick Guy D, Huang Shao-Gang, He Xing-Xiang

机构信息

The Affiliated Dongguan Hospital of Guangzhou University of Chinese Medicine, Dongguan, China.

The Australian Paediatric Surveillance Unit, The University of Sydney, The Children's Hospital, Sydney, New South Wale, Australia.

出版信息

eGastroenterology. 2024 Dec 23;2(4):e100099. doi: 10.1136/egastro-2024-100099. eCollection 2024 Oct.

DOI:10.1136/egastro-2024-100099
PMID:39944265
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11770466/
Abstract

The sustained increase in antibiotic resistance leads to a declining trend in the eradication rate of () infection with antibiotic-based eradication regimens. Administration of a single probiotic shows limited efficacy in eradicating infection. This review indicates that faecal microbiota transplantation (FMT), a novel therapeutic approach, either as a monotherapy or adjunctive therapy, exhibits beneficial effects in terms of the eradication of infection and the prevention of adverse events. The role of FMT in eradication may be associated directly or indirectly with some therapeutic constituents within the faecal suspension, including bacteria, viruses, antimicrobial peptides and metabolites. In addition, variations in donor selection, faecal suspension preparation and delivery methods are believed to be the main factors determining the effectiveness of FMT for the treatment of infection. Future research should refine the operational procedures of FMT to achieve optimal efficacy for infection and explore the mechanisms by which FMT acts against .

摘要

抗生素耐药性的持续增加导致基于抗生素的根除方案对()感染的根除率呈下降趋势。单一益生菌的施用在根除感染方面显示出有限的疗效。本综述表明,粪便微生物群移植(FMT)作为一种新型治疗方法,无论是作为单一疗法还是辅助疗法,在根除感染和预防不良事件方面均显示出有益效果。FMT在根除方面的作用可能直接或间接与粪便悬液中的一些治疗成分有关,包括细菌、病毒、抗菌肽和代谢产物。此外,供体选择、粪便悬液制备和给药方法的差异被认为是决定FMT治疗感染有效性的主要因素。未来的研究应完善FMT的操作程序,以实现对感染的最佳疗效,并探索FMT对抗的作用机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ccc/11770466/23bc8c011423/egastro-2-4-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ccc/11770466/23bc8c011423/egastro-2-4-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ccc/11770466/23bc8c011423/egastro-2-4-g001.jpg

相似文献

1
Faecal microbiota transplantation for eradicating Helicobacter pylori infection: clinical practice and theoretical postulation.粪菌移植用于根除幽门螺杆菌感染:临床实践与理论假设
eGastroenterology. 2024 Dec 23;2(4):e100099. doi: 10.1136/egastro-2024-100099. eCollection 2024 Oct.
2
Sequential versus standard triple first-line therapy for Helicobacter pylori eradication.用于根除幽门螺杆菌的序贯疗法与标准三联一线疗法对比
Cochrane Database Syst Rev. 2016 Jun 28;2016(6):CD009034. doi: 10.1002/14651858.CD009034.pub2.
3
Tailored therapy guided by genotypic resistance from gastric mucosa samples in the first-line treatment of infection: a systematic review and meta-analysis.基于胃黏膜样本基因型耐药指导的一线治疗感染的个体化疗法:一项系统评价和荟萃分析。
Therap Adv Gastroenterol. 2025 Jun 26;18:17562848251348826. doi: 10.1177/17562848251348826. eCollection 2025.
4
Periodontal therapy as adjunctive treatment for gastric Helicobacter pylori infection.牙周治疗作为胃幽门螺杆菌感染的辅助治疗
Cochrane Database Syst Rev. 2016 Feb 7;2(2):CD009477. doi: 10.1002/14651858.CD009477.pub2.
5
Helicobacter pylori and gastric or duodenal ulcer.幽门螺杆菌与胃或十二指肠溃疡。
Prescrire Int. 2016 Jan;25(167):18-23.
6
Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).粪便微生物移植治疗复发性艰难梭菌(艰难梭菌)。
Cochrane Database Syst Rev. 2023 Apr 25;4(4):CD013871. doi: 10.1002/14651858.CD013871.pub2.
7
Non-invasive diagnostic tests for Helicobacter pylori infection.幽门螺杆菌感染的非侵入性诊断测试。
Cochrane Database Syst Rev. 2018 Mar 15;3(3):CD012080. doi: 10.1002/14651858.CD012080.pub2.
8
Pharmacological regimens for eradication of Helicobacter pylori: an overview of systematic reviews and network meta-analysis.根除幽门螺杆菌的药物治疗方案:系统评价与网状Meta分析概述
BMC Gastroenterol. 2016 Jul 26;16(1):80. doi: 10.1186/s12876-016-0491-7.
9
H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer.幽门螺杆菌根除疗法与抗分泌非根除疗法(无论是否联合长期维持抗分泌疗法)用于预防消化性溃疡复发性出血的比较
Cochrane Database Syst Rev. 2003(4):CD004062. doi: 10.1002/14651858.CD004062.
10
H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer.幽门螺杆菌根除疗法与抗分泌非根除疗法(无论是否联合长期维持抗分泌疗法)用于预防消化性溃疡复发性出血的比较
Cochrane Database Syst Rev. 2004(2):CD004062. doi: 10.1002/14651858.CD004062.pub2.

引用本文的文献

1
Gut microbiota dysbiosis in inflammatory bowel disease: interaction with intestinal barriers and microbiota-targeted treatment options.炎症性肠病中的肠道微生物群失调:与肠道屏障的相互作用及针对微生物群的治疗选择
Front Cell Infect Microbiol. 2025 Jun 27;15:1608025. doi: 10.3389/fcimb.2025.1608025. eCollection 2025.

本文引用的文献

1
A Bifidobacterium animalis subsp. lactis strain that can suppress Helicobacter pylori: isolation, in vitro and in vivo validation.一株能抑制幽门螺杆菌的动物双歧杆菌亚种乳杆菌:分离、体外和体内验证。
Lett Appl Microbiol. 2024 Jan 2;77(1). doi: 10.1093/lambio/ovae005.
2
Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.肠易激综合征的粪便微生物群移植:随机对照试验的系统评价和荟萃分析。
Int J Mol Sci. 2023 Sep 26;24(19):14562. doi: 10.3390/ijms241914562.
3
NCFM and Lp-115 inhibit colonization and gastric inflammation in a murine model.
NCFM 和 Lp-115 抑制了小鼠模型中的定植和胃炎症。
Front Cell Infect Microbiol. 2023 Aug 9;13:1196084. doi: 10.3389/fcimb.2023.1196084. eCollection 2023.
4
Probiotic containing Lactobacillus reuteri DSM 17648 as an adjunct treatment for Helicobacter pylori infection: A randomized, double-blind, placebo-controlled trial.含罗伊氏乳杆菌 DSM 17648 的益生菌作为幽门螺杆菌感染的辅助治疗:一项随机、双盲、安慰剂对照试验。
Helicobacter. 2023 Dec;28(6):e13017. doi: 10.1111/hel.13017. Epub 2023 Aug 23.
5
The effectiveness of treatment with probiotics in eradication: results from an umbrella meta-analysis on meta-analyses of randomized controlled trials.益生菌治疗根除的疗效:对随机对照试验荟萃分析的伞状荟萃分析结果。
Food Funct. 2023 Aug 14;14(16):7654-7662. doi: 10.1039/d3fo00300k.
6
Lactiplantibacillus plantarum ZJ316 Reduces Helicobacter pylori Adhesion and Inflammation by Inhibiting the Expression of Adhesin and Urease Genes.植物乳杆菌 ZJ316 通过抑制黏附素和尿素酶基因的表达减少幽门螺杆菌的黏附和炎症。
Mol Nutr Food Res. 2023 Sep;67(18):e2300241. doi: 10.1002/mnfr.202300241. Epub 2023 Jul 23.
7
Inhibitory activity of Limosilactobacillus reuteri isolated from camel milk against Helicobacter pylori effects in human gastric epithelial cells.从骆驼奶中分离的罗伊氏乳杆菌对人胃上皮细胞中幽门螺杆菌的抑制活性。
Biotechnol Appl Biochem. 2023 Dec;70(6):1941-1953. doi: 10.1002/bab.2501. Epub 2023 Jul 20.
8
Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor-induced colitis.粪便微生物移植通过改变微生物组对难治性免疫检查点抑制剂诱导的结肠炎有效。
Sci Transl Med. 2023 Jun 14;15(700):eabq4006. doi: 10.1126/scitranslmed.abq4006.
9
Comparative effectiveness of different probiotics supplements for triple helicobacter pylori eradication: a network meta-analysis.不同益生菌补充剂对三联幽门螺杆菌根除效果的比较:网络荟萃分析。
Front Cell Infect Microbiol. 2023 May 15;13:1120789. doi: 10.3389/fcimb.2023.1120789. eCollection 2023.
10
Phenyl lactic acid alleviates infection in C57BL/6 mice.苯乳酸缓解 C57BL/6 小鼠的感染。
Food Funct. 2023 Jun 6;14(11):5032-5047. doi: 10.1039/d3fo00099k.